Fig. 2

FOSB is downregulated and associated with better relapse-free survival in TNBC. a The mRNA expression of FOSB between 115 TNBC and 113 non‐tumor tissues in TCGA dataset. b GSEA plot of HALLMARK_P53 and KRAS_SIGNALING_down pathways enrichment in 115 TNBC samples with lower FOSB expression. c Survival curve of FOSB is plotted for TNBC patients. d Survival curve of FOSB is plotted for Her2-negative breast cancer patients